About Novo Medi
Novo Medi is a company based in Mumbai (India) founded in 1946 by Anju Gupta Kaudanya. It operates as a B2B. The company has 262 employees as of March 31, 2023. Novo Medi operates in a competitive market with competitors including Moderna, Adaptive Biotechnologies, Chimerix, HOOKIPA Pharma and Novavax, among others.
- Headquarter Mumbai, India
- Employees 262 as on 31 Mar, 2023
- Founders Anju Gupta Kaudanya
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Novo Medi Sciences Private Limited
- Date of Incorporation 29 Jun, 2013
- Jurisdiction Mumbai, Maharashtra, India
-
Annual Revenue
$11.57 M (USD)-2.57as on Mar 31, 2023
-
Net Profit
$63.66 K (USD)-3.36as on Mar 31, 2023
-
EBITDA
$1.21 M (USD)-20.31as on Mar 31, 2023
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
262
as on Mar 31, 2023
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Novo Medi
Detailed funding history for Novo Medi
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Novo Medi
Investment portfolio details for Novo Medi
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Novo Medi
Detailed financials for Novo Medi
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Novo Medi Comparisons
Peer comparison for Novo Medi
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Novo Medi
Novo Medi operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, Adaptive Biotechnologies, Chimerix, HOOKIPA Pharma and Novavax, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| Locked | Locked | Locked |
Clinical diagnostics and drug discovery for immune diseases are provided.
|
|
| Locked | Locked | Locked |
Antiviral oral therapeutics are developed for infectious diseases and cancers.
|
|
| Locked | Locked | Locked |
Developer of immunotherapies for the treatment of infectious diseases and cancer
|
|
| Locked | Locked | Locked |
Novel vaccines are developed using nanoparticle and matrix adjuvant technology.
|
|
| Locked | Locked | Locked |
Developer of novel protein-based therapeutics using machine learning and biological engineering
|
Detailed competitors of Novo Medi
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Novo Medi
Complete news archive for Novo Medi
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Novo Medi
Novo Medi was founded in 1946.
Novo Medi is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Anju Gupta Kaudanya is the current CEO of Novo Medi. They have also founded this company.
As of Mar 31, 2023, the latest employee count at Novo Medi is 262.
Annual revenue of Novo Medi is $11.57M as on Mar 31, 2023.
Novo Medi, established in 1946, excels in providing healthcare solutions, producing pharmaceutical products, vaccine development, and viral vaccines. Develops and manufactures vaccines for viral infections. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide.
Novo Medi's top competitors include Moderna, Adaptive Biotechnologies and Generate Biomedicines.